Effect of Physical Training in Individuals With Hypokalemic and Hyperkalemic Periodic Paralysis
NCT ID: NCT07194174
Last Updated: 2025-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
36 participants
INTERVENTIONAL
2025-10-01
2026-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators wishes to include participants already diagnosed with either HypoPP or HyperPP in af 24 week prospective study where the patients will be tested and asked to fill out questionnaires three times. These appointments will be schedueled at week 0, week 12 and week 24.
In the time period between week 12 and week 24, the patients will have a personalized strength exercise program, which they will have to follow these 3 months. The exercise will be supervised by one or more of the investigators.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Intensity Training in Patients With Spinal and Bulbar Muscular Atrophy
NCT02156141
Expiratory Muscle Training and Trunk Flexion in Parkinson's Disease
NCT06963918
The Regulation of Human Skeletal Muscle Mass by Contractile Perturbation
NCT03046095
Periodization and Parkinson's Disease
NCT07141849
Stretch-Shortening Cycle Exercise: Potential Implications For Children With Obstetric Brachial Plexus Injury
NCT06157476
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hypo-/HyperPP
Strength exercise will be implemented for all participants included in this study. The first 12 weeks will be without intervention and after this period the intervention will begin. The participants are therefore all controls (no intervention) and experimental (intervention).
Strength exercise
3 weekly supervised trainings with specific strengt exercises
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Strength exercise
3 weekly supervised trainings with specific strengt exercises
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age minimum 18 years
* Able to walk a minimum of 10 meters independently with or without assistive devices and be able to stand from a chair without using hands
Exclusion Criteria
* Heart or lung disease which, in the investigator's opinion, makes participation in the study training inadvisable
Exclusion from muscle biopsy
* Anticoagulant treatment
* Impaired blood clotting due to disease
Exclusion from MRI scanning due to:
* Metal implants in the body that contraindicate MRI scanning or are positioned such that the scan quality is significantly affected
* Claustrophobia
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Annica Buss Enegaard
BSc
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-25003151
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.